LeMaitre projects $280M revenue and $2.91 EPS for 2026 with 12% organic sales growth, driven by international expansion and Artegraft
Source: SeekingAlpha
2026-02-26 01:48:20 ET
More on LeMaitre Vascular
- LeMaitre Vascular, Inc. (LMAT) Q4 2025 Earnings Call Transcript
- LeMaitre Vascular Q4 2025 Earnings Preview
- Seeking Alpha’s Quant Rating on LeMaitre Vascular
- Historical earnings data for LeMaitre Vascular
- Dividend scorecard for LeMaitre Vascular
Read the full article on Seeking Alpha
For further details see:
LeMaitre projects $280M revenue and $2.91 EPS for 2026 with 12% organic sales growth, driven by international expansion and Artegraft
LeMaitre Vascular Inc.
NASDAQ: LMAT
LMAT Trading
2.24% G/L:
$107.33 Last:
44,868 Volume:
$107.30 Open:
LMAT Latest News
February 11, 2026 09:47:47 am
LeMaitre Will Announce Fourth Quarter 2025 Earnings Results February 25, 2026
LMAT Stock Data
$1,988,654,234
20,530,825
0.06%
117
N/A
Medical Equipment & Supplies
Healthcare
US
Burlington
